Suxiao Jiuxin Pill for unstable plaque after heart attack
Part of Heart & circulation clinical trials.
This Phase 4 trial studies whether Suxiao Jiuxin Pill can stabilize “vulnerable” plaque in people after an acute heart attack. It may help reduce risky heart-related complications when doctors are planning emergency coronary angiography and stent/PCI treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You were diagnosed with an acute heart attack and admitted from the emergency department
- Doctors plan an emergency coronary angiography and PCI (reopening blocked artery)
- You can sign informed consent to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if Qishenyiqi, a Chinese herbal medicine, can help your heart rebuild and work better after a heart attack. It is for people whose heart function is still weak and who have heart failure symptoms.
This trial tests if a Chinese herbal pill called Qishenyiqi can help people with chest pain caused by tiny heart blood vessels that are too tight. It may be an option if standard tests show your heart vessels are mostly clear but your blood flow is reduced.
This trial tests if a traditional Chinese medicine pill (Shexiang Baoxin) can help people having a heart attack. It is given along with standard care, including a procedure to open blocked heart arteries (PCI).
This trial tests whether Xuesaitong Soft Capsules can help people who recently had a heart attack or unstable angina and received a stent. It aims to see if adding this medicine improves recovery and reduces future heart problems.
This study tracks people who had an ischemic stroke (a type of stroke caused by blocked blood flow) within the last week and received Suhexiang Pill. It aims to see how outcomes and follow-up go in real-world use, which may help doctors understand who might benefit and how to monitor patients.
This trial tests if adding the herbal injection Shuxuening to standard clot-busting treatment improves recovery for people having an ischemic stroke. It is for adults within 6 hours of symptom onset who are already receiving a clot-dissolving medication.
Hear when a new Acute Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.